{
    "title": "AstraZeneca profits as Crestor sales boom",
    "url": "https://www.dailymail.co.uk/money/markets/article-1711590/AstraZeneca-profits-as-Crestor-sales-boom.html",
    "date": "2011-01-27",
    "keywords": [
        "drug",
        "crestor",
        "exclusivity",
        "range",
        "profit",
        "quarter",
        "sale",
        "growth",
        "group",
        "core",
        "product",
        "medicine",
        "performance",
        "europe",
        "firm",
        "revenue",
        "competition",
        "period",
        "boom",
        "money",
        "gmt",
        "view",
        "astrazeneca",
        "note",
        "caution",
        "fall",
        "rise",
        "year",
        "astra",
        "cholesterol",
        "treatment",
        "symbicort",
        "seroquel",
        "disorder",
        "stock",
        "executive",
        "david",
        "brennan",
        "strength",
        "resilience",
        "business",
        "government",
        "pressure",
        "pricing",
        "patent",
        "loss",
        "market",
        "breast",
        "cancer",
        "arimidex",
        "month",
        "lowsingle",
        "digit",
        "decline",
        "level",
        "outlook",
        "industry",
        "company",
        "base",
        "lung",
        "disease",
        "accounting",
        "charge",
        "approval",
        "heart",
        "food",
        "administration",
        "analysis",
        "bloodthinning",
        "pill",
        "staff",
        "uk",
        "macclesfield",
        "wilmslow",
        "cheshire",
        "luton",
        "edinburgh",
        "brixham",
        "devon",
        "focus",
        "brilinta",
        "wake"
    ],
    "category": [
        "money",
        "markets"
    ]
}